Fast Homogeneous Assay for Plasma Procarboxypeptidase U
- 7 January 2001
- journal article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 39 (9) , 806-10
- https://doi.org/10.1515/cclm.2001.133
Abstract
Carboxypeptidase U (EC 3.4.17.20, CPU, TAFIa) is a novel determinant of the fibrinolytic rate. It circulates as an inactive zymogen, procarboxypeptidase U, which becomes active during the process of coagulation. We developed a high throughput method on microtiter plates for the determination of the procarboxypeptidase U concentration in human plasma samples. Following activation of procarboxypeptidase U by thrombin-thrombomodulin, the resulting enzyme activity cleaves p-OH-Hip-Arg and the generated p-OH-hippuric acid is converted by hippuricase to p-hydroxybenzoic acid and glycine. Finally, oxidative coupling of p-hydroxybenzoic acid with 4-aminoantipyrine by NaIO4 forms the quinoneimine dye. The absorbance of the latter dye is determined at 506 nm in a microtiter plate reader. A mean value of 620 U/l was found, with a CV of 3.0% within-run and 4.3% between-run. The assay showed a good correlation with the activities observed using a HPLC assay as reference method (n = 25, r = 0.979). The presented method enables the routine analysis of large sample pools in clinical setting.Keywords
This publication has 26 references indexed in Scilit:
- arboxypeptidase U at the Interface Between Coagulation and FibrinolysisClinical and Applied Thrombosis/hemostasis, 2001
- Immunological Assay for the Determination of Procarboxypeptidase U Antigen Levels in Human PlasmaThrombosis and Haemostasis, 2001
- Proteolytic activation of purified human procarboxypeptidase UClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- Plasma TAFI Levels Influence the Clot Lysis Time in Healthy Individuals in the Presence of an Intact Intrinsic Pathway of CoagulationThrombosis and Haemostasis, 1998
- Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.Journal of Clinical Investigation, 1997
- The Plasma Carboxypeptidases and the Regulation of the Plasminogen SystemTrends in Cardiovascular Medicine, 1997
- Inducible Carboxypeptidase ActivityCirculation, 1996
- Plasma carboxypeptidases as regulators of the plasminogen system.Journal of Clinical Investigation, 1995
- Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1995
- Basic carboxypeptidases: regulators of peptide hormone activityTrends in Pharmacological Sciences, 1988